Study to avoid low blood sugar after meals
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests if a quick-acting glucagon nasal spray can prevent low blood sugar after meals in people with type 1 diabetes who use an automated insulin pump. If you count carbs and use NovoRapid or Fiasp insulin, this could help you avoid post-meal lows.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had type 1 diabetes for at least 2 years.
- You have been using an automated insulin delivery system (like a closed-loop pump) for at least 3 months.
- You have been using NovoRapid or Fiasp insulin for at least 1 week.
- You know how to count carbohydrates in your meals.
- You do not have allergies to lactose or glucagon, or certain tumors or stomach problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests if adding a non-insulin medication can lower the amount of insulin needed while improving heart and metabolic health in people with type 1 diabetes. It may also help understand how this approach works in people with a genetic form of diabetes (GCK-MODY).
This study looks at how timing your insulin bolus (the extra insulin you take with meals) can improve blood sugar control. It involves adults with type 1 diabetes who are already using the MiniMed 780G pump with Novorapid insulin.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This study tests whether very low-carbohydrate diets change glucagon response in adults with type 1 diabetes. It may help researchers understand how diet affects blood-sugar control in people using insulin pumps and continuous glucose monitors.
This trial tests whether a closed-loop insulin pump combined with education can help people with type 1 diabetes better recognize and avoid dangerously low blood sugar. It may be a good fit if you've had diabetes for a long time and have trouble sensing when your blood sugar drops.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.